Los puntos clave no están disponibles para este artículo en este momento.
Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer's disease have not been extensively investigated in longitudinal studies.
Jia et al. (Wed,) studied this question.